Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FQQWW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,316
Award facts
- Contract value 100% obligated
- $21,316.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,316.00 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors on May 12, 2025, with an ultimate completion date of May 13, 2025. This firm fixed-price delivery order, issued without set-aside designation, was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Zepbound is a pharmaceutical product used in diabetes and weight management treatment, reflecting the contractor's role as a critical supplier of specialty medications to federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor headquartered in Pennsylvania, demonstrates extensive capability in fulfilling federal medical procurement requirements across multiple therapeutic domains through its portfolio of competitively awarded contracts with the DLA.
Quick answers
Who was awarded contract SPE2DB25FQQWW?
SPE2DB25FQQWW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 12, 2025.
How much is contract SPE2DB25FQQWW worth?
The government has obligated $21,316 on SPE2DB25FQQWW.
Is contract SPE2DB25FQQWW an order under another contract?
Yes. SPE2DB25FQQWW is a delivery order under SPE2DB25D2207, an indefinite delivery contract.
Was contract SPE2DB25FQQWW competed?
The extent of competition for SPE2DB25FQQWW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award